Media Library

Sickle cell disease (SCD) is a hereditary blood disorder characterized by sickleshaped red blood cells.

Thalassemia refers to a diverse family of genetic disorders characterized by an underproduction of hemoglobin, a protein in red blood cells that carries oxygen.

Despite progress, billions of people still live at the bottom of the pyramid and lack access to essential healthcare. Our Healthy Family programs aim at expanding access to community education, improved infrastructure and affordable healthcare products in India, Vietnam and Kenya – in a sustainable way.

The burden of noncommunicable diseases is increasing in the developing world, where people often have limited resources to get the care they need. Novartis Access aims to bring affordable treatments for key chronic diseases like cardiovascular diseases, diabetes and cancer to patients in lower-income countries.

Non-alcoholic steatohepatitis (NASH) is a more severe, progressive form of non-alcoholic fatty liver disease (NAFLD). The prevalence of NAFLD in Western countries is 20-30%, and it is estimated that 2-3% of the population has NASH.

Chief Legal and Compliance Officer since April, 2025Member of the Executive Committee

This B-roll includes a collection of footage of Novartis pharmaceutical manufacturing, production and packaging.

Manufacturing process of a cell and gene therapy (CAR-T)